Black Breast Cancer Survivors' Support and Wellness Course (BBCSI)
Official title: Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)
Run by M.D. Anderson Cancer Center · NCT06885203 · Data updated 2026-11-12
This project will test whether a community-based, peer-led BBCSI course can improve quality of life for Black women with stage 0–III breast cancer who are within four years of diagnosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 56 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | August 27, 2025 |
| Main results expected | August 31, 2027 |
| Study ends | August 31, 2029 |
| Registry record updated | August 12, 2026 |
| Trial ID | NCT06885203 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking Black women aged 18 or older with histologically confirmed stage 0–III breast cancer, no metastatic disease, and within four years of diagnosis.
✕Probably not a fit
Women with metastatic (stage IV) disease or those unable to attend sessions in Houston or communicate in English are unlikely to receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Black Breast Cancer Survivor's Intervention (BBCSI) is a community-based, peer-led curriculum designed to support Black women after non-metastatic breast cancer. The study will develop a prototype BBCSI course, train master trainers and community interventionists, and enroll eligible participants to take the program. Outcomes include participant satisfaction and preliminary effects on quality of life, along with measures of fidelity, feasibility, acceptability, and barriers or facilitators to delivery. The trial activities are based at The University of Texas M. D. Anderson Cancer Center in Houston, Texas.
Why it matters
Potential benefit: If successful, the program could improve overall quality of life, coping, and social support for Black breast cancer survivors.
How similar studies have gone: Peer-led survivorship programs have shown promise for improving quality of life in breast cancer survivors, but culturally tailored interventions specifically for Black survivors are relatively novel and less extensively studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Master Trainers: To be eligible to participate in this study, an individual must meet all the following criteria: 1. Adult women aged 18 years and older 2. Histologically confirmed stage 0-III breast cancer 3. No evidence of metastatic disease 4. Self-identify as Black 5. Able to communicate in English Participants: To be eligible to participate in this study, an individual must meet all the following criteria: 1. Adult women aged 18 years and older 2. Histologically confirmed stage 0-III breast cancer 3. No evidence of metastatic disease 4. Self-identify as Black 5. Able to communicate in English Community Interventionists: To be eligible to participate in this study, an individual must meet all the following criteria: 1. Adult women aged 18 years and older 2. Histologically confirmed stage 0-III breast cancer 3. No evidence of metastatic disease 4. Self-identify as Black 5. Former study participants that have completed the intervention 6. Able to communicate in English General Exclusion Criteria: 1. Men or woman below 18 years of age 2. Does not have a histologically confirmed breast cancer 3. There's evidence of metastatic disease 4. Does not self-identify as Black 5. Unable to communicate in English Additional Exclusion Criteria - Community Interventionists 1\. Has not previously participated in and completed the study intervention as a participant
Where it's running
-
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Dede Teteh-Brooks, DRPH — M.D. Anderson Cancer Center
- Study coordinator: Dede Teteh-Brooks, DRPH
- Email: dkteteh@mdanderson.org
- Phone: 713-563-3493
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.